Sarepta Therapeutics, Inc. Message Board
-
Piper Jaffary " Near Term for SRPT $60-$80. After Approval $160. **link**
Street Insider
Sarepta Therapeutics (SRPT) Jumps on Bullish Comments
November 21, 2012 9:18 AM EST
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.-
thanks
-
just think last month these guys had the lowest target price of all the analyst and look now ,the highest and bullish remarks a month and a few days later
-
analysts love this drug.
-
thanks
-
taking off !!
- 3 Replies to greenjohn146
-
if I miss this like last time , i will kick myself.
-
good link, thanks
-
score !!!
-
36.911.40(+3.94%)May 17 4:00 PMEDT